The many faces of c-MYC
- 17 July 2003
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 416 (2) , 129-136
- https://doi.org/10.1016/s0003-9861(03)00294-7
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- E2F1 and c-Myc Potentiate Apoptosis through Inhibition of NF-κB Activity that Facilitates MnSOD-Mediated ROS EliminationMolecular Cell, 2002
- Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trialJournal of the American College of Cardiology, 2002
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- MycN and IFNγ cooperate in apoptosis of human neuroblastoma cellsOncogene, 1998
- Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activityOncogene, 1997
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with MycScience, 1991
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985